ルビプロストンの世界市場 2020年

• 英文タイトル：Global Lubiprostone Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115832 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、ルビプロストンの世界市場を調査対象にし、ルビプロストンの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（8 mcgカプセル、24 mcgカプセル）、用途別分析（CIC及びOIC、IBS-C）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Takeda Pharmaceuticals ・企業別売上、市場シェア ・ルビプロストンの地域別市場分析 ・ルビプロストンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ルビプロストンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ルビプロストンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ルビプロストンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ルビプロストンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ルビプロストンの種類別市場規模2015-2020：8 mcgカプセル、24 mcgカプセル ・ルビプロストンの用途別市場規模2015-2020：CIC及びOIC、IBS-C ・ルビプロストンの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Lubiprostone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Lubiprostone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Lubiprostone market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Lubiprostone market has been segmented into:
8 mcg Capsules
24 mcg Capsules

By Application, Lubiprostone has been segmented into:
CIC and OIC
IBS-C

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lubiprostone market presented in the report. This section sheds light on the sales growth of different regional and country-level Lubiprostone markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lubiprostone market.

The report offers in-depth assessment of the growth and other aspects of the Lubiprostone market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Lubiprostone Market Share Analysis
Lubiprostone competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lubiprostone sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lubiprostone sales, revenue and market share for each player covered in this report.

The major players covered in Lubiprostone are:
Takeda Pharmaceuticals

レポート目次

---

1 Lubiprostone Market Overview
1.1 Product Overview and Scope of Lubiprostone
1.2 Classification of Lubiprostone by Type
1.2.1 Global Lubiprostone Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Lubiprostone Revenue Market Share by Type in 2019
1.2.3 8 mcg Capsules
1.2.4 24 mcg Capsules
1.3 Global Lubiprostone Market by Application
1.3.1 Overview: Global Lubiprostone Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 CIC and OIC
1.3.3 IBS-C
1.4 Global Lubiprostone Market by Regions
1.4.1 Global Lubiprostone Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Lubiprostone (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Lubiprostone Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Lubiprostone Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lubiprostone Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Lubiprostone Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lubiprostone Status and Prospect (2015-2025)
2 Company Profiles
2.1 Takeda Pharmaceuticals
2.1.1 Takeda Pharmaceuticals Details
2.1.2 Takeda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Takeda Pharmaceuticals SWOT Analysis
2.1.4 Takeda Pharmaceuticals Product and Services
2.1.5 Takeda Pharmaceuticals Lubiprostone Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Lubiprostone Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Lubiprostone Players Market Share
3.2.2 Top 10 Lubiprostone Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Lubiprostone Revenue and Market Share by Regions
4.2 North America Lubiprostone Revenue and Growth Rate (2015-2020)
4.3 Europe Lubiprostone Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Lubiprostone Revenue and Growth Rate (2015-2020)
4.5 South America Lubiprostone Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Lubiprostone Revenue and Growth Rate (2015-2020)
5 North America Lubiprostone Revenue by Countries
5.1 North America Lubiprostone Revenue by Countries (2015-2020)
5.2 USA Lubiprostone Revenue and Growth Rate (2015-2020)
5.3 Canada Lubiprostone Revenue and Growth Rate (2015-2020)
5.4 Mexico Lubiprostone Revenue and Growth Rate (2015-2020)
6 Europe Lubiprostone Revenue by Countries
6.1 Europe Lubiprostone Revenue by Countries (2015-2020)
6.2 Germany Lubiprostone Revenue and Growth Rate (2015-2020)
6.3 UK Lubiprostone Revenue and Growth Rate (2015-2020)
6.4 France Lubiprostone Revenue and Growth Rate (2015-2020)
6.5 Russia Lubiprostone Revenue and Growth Rate (2015-2020)
6.6 Italy Lubiprostone Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Lubiprostone Revenue by Countries
7.1 Asia-Pacific Lubiprostone Revenue by Countries (2015-2020)
7.2 China Lubiprostone Revenue and Growth Rate (2015-2020)
7.3 Japan Lubiprostone Revenue and Growth Rate (2015-2020)
7.4 Korea Lubiprostone Revenue and Growth Rate (2015-2020)
7.5 India Lubiprostone Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Lubiprostone Revenue and Growth Rate (2015-2020)
8 South America Lubiprostone Revenue by Countries
8.1 South America Lubiprostone Revenue by Countries (2015-2020)
8.2 Brazil Lubiprostone Revenue and Growth Rate (2015-2020)
8.3 Argentina Lubiprostone Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Lubiprostone by Countries
9.1 Middle East & Africa Lubiprostone Revenue by Countries (2015-2020)
9.2 Saudi Arabia Lubiprostone Revenue and Growth Rate (2015-2020)
9.3 UAE Lubiprostone Revenue and Growth Rate (2015-2020)
9.4 Egypt Lubiprostone Revenue and Growth Rate (2015-2020)
9.5 South Africa Lubiprostone Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Lubiprostone Revenue and Market Share by Type (2015-2020)
10.2 Global Lubiprostone Market Forecast by Type (2019-2024)
10.3 8 mcg Capsules Revenue Growth Rate (2015-2025)
10.4 24 mcg Capsules Revenue Growth Rate (2015-2025)
11 Global Lubiprostone Market Segment by Application
11.1 Global Lubiprostone Revenue Market Share by Application (2015-2020)
11.2 Lubiprostone Market Forecast by Application (2019-2024)
11.3 CIC and OIC Revenue Growth (2015-2020)
11.4 IBS-C Revenue Growth (2015-2020)
12 Global Lubiprostone Market Size Forecast (2021-2025)
12.1 Global Lubiprostone Market Size Forecast (2021-2025)
12.2 Global Lubiprostone Market Forecast by Regions (2021-2025)
12.3 North America Lubiprostone Revenue Market Forecast (2021-2025)
12.4 Europe Lubiprostone Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Lubiprostone Revenue Market Forecast (2021-2025)
12.6 South America Lubiprostone Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Lubiprostone Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Lubiprostone Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lubiprostone by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lubiprostone Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Lubiprostone Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Takeda Pharmaceuticals Corporate Information, Location and Competitors
Table 6. Takeda Pharmaceuticals Lubiprostone Major Business
Table 7. Takeda Pharmaceuticals Lubiprostone Total Revenue (USD Million) (2017-2018)
Table 8. Takeda Pharmaceuticals SWOT Analysis
Table 9. Takeda Pharmaceuticals Lubiprostone Product and Solutions
Table 10. Takeda Pharmaceuticals Lubiprostone Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Global Lubiprostone Revenue (Million USD) by Players (2015-2020)
Table 12. Global Lubiprostone Revenue Share by Players (2015-2020)
Table 13. Global Lubiprostone Revenue (Million USD) by Regions (2015-2020)
Table 14. Global Lubiprostone Revenue Market Share by Regions (2015-2020)
Table 15. North America Lubiprostone Revenue by Countries (2015-2020)
Table 16. North America Lubiprostone Revenue Market Share by Countries (2015-2020)
Table 17. Europe Lubiprostone Revenue (Million USD) by Countries (2015-2020)
Table 18. Asia-Pacific Lubiprostone Revenue (Million USD) by Countries (2015-2020)
Table 19. South America Lubiprostone Revenue by Countries (2015-2020)
Table 20. South America Lubiprostone Revenue Market Share by Countries (2015-2020)
Table 21. Middle East and Africa Lubiprostone Revenue (Million USD) by Countries (2015-2020)
Table 22. Middle East and Africa Lubiprostone Revenue Market Share by Countries (2015-2020)
Table 23. Global Lubiprostone Revenue (Million USD) by Type (2015-2020)
Table 24. Global Lubiprostone Revenue Share by Type (2015-2020)
Table 25. Global Lubiprostone Revenue Forecast by Type (2021-2025)
Table 26. Global Lubiprostone Revenue by Application (2015-2020)
Table 27. Global Lubiprostone Revenue Share by Application (2015-2020)
Table 28. Global Lubiprostone Revenue Forecast by Application (2021-2025)
Table 29. Global Lubiprostone Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Lubiprostone Picture
Figure 2. Global Lubiprostone Revenue Market Share by Type in 2019
Figure 3. 8 mcg Capsules Picture
Figure 4. 24 mcg Capsules Picture
Figure 5. Lubiprostone Revenue Market Share by Application in 2019
Figure 6. CIC and OIC Picture
Figure 7. IBS-C Picture
Figure 8. Global Lubiprostone Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Lubiprostone Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Lubiprostone Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Lubiprostone Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Lubiprostone Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Lubiprostone Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Lubiprostone Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Lubiprostone Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Lubiprostone Revenue Market Share in 2019
Figure 17. Global Top 10 Players Lubiprostone Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Lubiprostone Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Lubiprostone Revenue Market Share by Regions (2015-2020)
Figure 21. Global Lubiprostone Revenue Market Share by Regions in 2018
Figure 22. North America Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 23. Europe Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 25. South America Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 27. North America Lubiprostone Revenue Market Share by Countries (2015-2020)
Figure 28. North America Lubiprostone Revenue Market Share by Countries in 2019
Figure 29. USA Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 30. Canada Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 32. Europe Lubiprostone Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Lubiprostone Revenue Market Share by Countries in 2019
Figure 34. Germany Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 35. UK Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 36. France Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 37. Russia Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 38. Italy Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Lubiprostone Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Lubiprostone Revenue Market Share by Countries in 2019
Figure 41. China Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 42. Japan Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 43. Korea Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 44. India Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 46. South America Lubiprostone Revenue Market Share by Countries (2015-2020)
Figure 47. South America Lubiprostone Revenue Market Share by Countries in 2019
Figure 48. Brazil Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Lubiprostone Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Lubiprostone Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 53. UAE Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Lubiprostone Revenue and Growth Rate (2015-2020)
Figure 56. Global Lubiprostone Revenue Share by Type (2015-2020)
Figure 57. Global Lubiprostone Revenue Share by Type in 2019
Figure 58. Global Lubiprostone Market Share Forecast by Type (2021-2025)
Figure 59. Global 8 mcg Capsules Revenue Growth Rate (2015-2020)
Figure 60. Global 24 mcg Capsules Revenue Growth Rate (2015-2020)
Figure 61. Global Lubiprostone Revenue Share by Application (2015-2020)
Figure 62. Global Lubiprostone Revenue Share by Application in 2019
Figure 63. Global Lubiprostone Market Share Forecast by Application (2021-2025)
Figure 64. Global CIC and OIC Revenue Growth Rate (2015-2020)
Figure 65. Global IBS-C Revenue Growth Rate (2015-2020)
Figure 66. Global Lubiprostone Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Lubiprostone Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Lubiprostone Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Lubiprostone Revenue Market Forecast (2021-2025)
Figure 70. Europe Lubiprostone Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Lubiprostone Revenue Market Forecast (2021-2025)
Figure 72. South America Lubiprostone Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Lubiprostone Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---